Source link : https://www.newshealth.biz/health-news/do-sglt2-inhibitors-benefit-everyone-with-t2d-and-ckd/
MADRID, Spain — Nearly half of people with type 2 diabetes (T2D) currently recommended to receive sodium-glucose cotransporter 2 (SGLT2) inhibitors for kidney protection would not actually benefit from them, new research suggests. Current guidelines recommend SGLT2 inhibitors for kidney protection for a broad range of people with T2D, but many weren’t represented in key […]
Author : News Health
Publish date : 2024-09-10 15:09:05
Copyright for syndicated content belongs to the linked Source.